Scopus Asset Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-110,000
Closed -$12.1M 379
2021
Q1
$12.1M Buy
+110,000
New +$11.9M 0.15% 167
2020
Q4
Sell
-303,225
Closed -$23.7M 334
2020
Q3
$23.7M Buy
303,225
+156,550
+107% +$11.8M 0.46% 65
2020
Q2
$10.2M Sell
146,675
-108,425
-43% -$6.83M 0.29% 112
2020
Q1
$11.9M Buy
+255,100
New +$16.4M 1.02% 31
2019
Q4
Sell
-75,000
Closed -$5.54M 151
2019
Q3
$5.54M Buy
+75,000
New +$5.38M 0.18% 105
2018
Q2
Sell
-200,000
Closed -$21.1M 302
2018
Q1
$21.1M Buy
200,000
+150,000
+300% +$15.2M 0.2% 146
2017
Q4
$4.63M Buy
50,000
+10,000
+25% +$909K 0.04% 258
2017
Q3
$3.62M Sell
40,000
-135,000
-77% -$11.5M 0.04% 248
2017
Q2
$14.7M Buy
175,000
+100,000
+133% +$8.06M 0.16% 148
2017
Q1
$6.06M Buy
75,000
+25,000
+50% +$1.97M 0.09% 172
2016
Q4
$3.76M Sell
50,000
-125,000
-71% -$9.03M 0.08% 147
2016
Q3
$11.8M Buy
+175,000
New +$11.7M 0.19% 116
2016
Q1
Sell
-35,000
Closed -$2.36M 209
2015
Q4
$2.36M Buy
35,000
+5,000
+17% +$350K 0.07% 123
2015
Q3
$1.94M Sell
30,000
-180,000
-86% -$13.3M 0.05% 143
2015
Q2
$17.2M Buy
+210,000
New +$16.2M 0.3% 97
2014
Q4
Sell
-115,180
Closed -$9.32M 189
2014
Q3
$9.32M Sell
115,180
-186,243
-62% -$15.5M 0.19% 105
2014
Q2
$26.3M Buy
301,423
+176,979
+142% +$15.4M 0.6% 52
2014
Q1
$10.7M Sell
124,444
-51,756
-29% -$4.24M 0.29% 99
2013
Q4
$14.2M Buy
176,200
+121,326
+221% +$9.42M 0.33% 88
2013
Q3
$4.28M Buy
+54,874
New +$4.23M 0.11% 134

Other funds holding EMN

Scopus Asset Management's EMN Position: Q2 2021 in Review

Scopus Asset Management sold out of Eastman Chemical (EMN) in Q2 2021, closing a stake of 110,000 shares — an estimated $12.1M sold.

Scopus Asset Management first reported a position in EMN in Q3 2013 and held it in 20 quarters. The position peaked at $26.3M in Q2 2014. 723 funds tracked by Wall St. Rank hold EMN as of Q2 2021.

  • Scopus Asset Management reported no remaining Eastman Chemical position as of Q2 2021 after selling out during the quarter.
  • Scopus Asset Management sold 110,000 Eastman Chemical shares in Q2 2021, an estimated $12.1M.
  • Scopus Asset Management first reported a position in Eastman Chemical in Q3 2013 and held it in 20 quarters.
  • Scopus Asset Management's Eastman Chemical position peaked at $26.3M in Q2 2014.
  • 723 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2021.

Based on Scopus Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.